What was the overall market valuation of the US cardiac pacemaker market in 2024?

The overall market valuation was $1176.0 Million in 2024. Read More

What is the projected market valuation for the US cardiac pacemaker market by 2035?

The projected valuation for 2035 is $1955.61 Million. Read More

What is the expected CAGR for the US cardiac pacemaker market during the forecast period 2025 - 2035?

The expected CAGR during the forecast period 2025 - 2035 is 4.73%. Read More

Which companies are considered key players in the US cardiac pacemaker market?

Key players include Medtronic, Boston Scientific, Abbott, Biotronik, St. Jude Medical, Sorin Group, Osypka, and MicroPort. Read More

What are the market segments based on technology for cardiac pacemakers?

The market segments based on technology include Single Chamber Pacemaker, Dual Chamber Pacemaker, and Biventricular Pacemaker. Read More

What were the market values for Single Chamber and Dual Chamber Pacemakers in 2024?

In 2024, the market value for Single Chamber Pacemakers was $400.0 Million, while Dual Chamber Pacemakers was $576.0 Million. Read More

What applications are included in the US cardiac pacemaker market?

Applications include Bradycardia, Atrial Fibrillation, and Heart Block. Read More

What was the market value for Bradycardia in 2024?

The market value for Bradycardia was $470.4 Million in 2024. Read More

What are the end-use segments for cardiac pacemakers?

End-use segments include Hospitals, Ambulatory Surgical Centers, and Home Care Settings. Read More

What were the market values for Hospitals and Ambulatory Surgical Centers in 2024?

In 2024, the market value for Hospitals was $705.0 Million, and for Ambulatory Surgical Centers, it was $294.0 Million. Read More

US Cardiac Pacemaker Market

ID: MRFR/MED/16391-HCR

100 Pages

Nidhi Mandole

Last Updated: April 06, 2026

US Cardiac Pacemaker Market Research Report: Size, Share, Trend Analysis By Technology (Single Chamber Pacemaker, Dual Chamber Pacemaker, Biventricular Pacemaker), By Applications (Bradycardia, Atrial Fibrillation, Heart Block), By End Use (Hospitals, Ambulatory Surgical Centers, Home Care Settings) and By Implantation Type (Transvenous Implantation, Epicardial Implantation, Leadless Implantation) - Growth Outlook & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Technology (USD Million)
  1. 4.1.1 Single Chamber Pacemaker
  2. 4.1.2 Dual Chamber Pacemaker
  3. 4.1.3 Biventricular Pacemaker
2. 4.2 Life Sciences, BY Application (USD Million)
  1. 4.2.1 Bradycardia
  2. 4.2.2 Atrial Fibrillation
  3. 4.2.3 Heart Block
3. 4.3 Life Sciences, BY End Use (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Ambulatory Surgical Centers
  3. 4.3.3 Home Care Settings
4. 4.4 Life Sciences, BY Implantation Type (USD Million)
  1. 4.4.1 Transvenous Implantation
  2. 4.4.2 Epicardial Implantation
  3. 4.4.3 Leadless Implantation
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medtronic (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Boston Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Abbott (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Biotronik (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 St. Jude Medical (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Sorin Group (IT)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Osypka (DE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 MicroPort (CN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END USE
5. 6.5 US MARKET ANALYSIS BY IMPLANTATION TYPE
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY END USE, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY END USE, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY IMPLANTATION TYPE, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY IMPLANTATION TYPE, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USE, 2025-2035 (USD Million)
  4. 7.2.4 BY IMPLANTATION TYPE, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Life Sciences Market Segmentation

Life Sciences By Technology (USD Million, 2025-2035)

Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker

Life Sciences By Application (USD Million, 2025-2035)

Bradycardia
Atrial Fibrillation
Heart Block

Life Sciences By End Use (USD Million, 2025-2035)

Hospitals
Ambulatory Surgical Centers
Home Care Settings

Life Sciences By Implantation Type (USD Million, 2025-2035)

Transvenous Implantation
Epicardial Implantation
Leadless Implantation

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”